Table 3 Patients characteristics according to HBV reactivation
Variable | HBsAg (−) Diffuse large B-cell lymphoma | P value | |
|---|---|---|---|
HBV reactivation | Non-HBV reactivation | ||
Sample size | 17 | 149 | Â |
Age, years | Â | Â | 0.869 |
  ≤ 60 | 11 (64.7%) | 94 (63.1%) |  |
  > 60 | 6 (35.3%) | 55 (36.9%) |  |
Gender | Â | Â | 0.911 |
 Male | 9 (52.9%) | 81 (54.3%) |  |
 Female | 8 (47.1%) | 68 (45.7%) |  |
B symptom | Â | Â | 0.542 |
 Positive | 5 (29.4%) | 55 (36.9%) |  |
 Negative | 12 (70.6%) | 94 (63.1%) |  |
IPI score | Â | Â | 0.108 |
 1–2 | 9 (52.9%) | 107 (71.8%) |  |
 3–5 | 8 (47.1%) | 42 (28.2%) |  |
LDH | Â | Â | 0.264 |
 Normal | 8 (47.1%) | 91 (61.1%) |  |
 Elevated | 9 (52.9%) | 58 (38.9%) |  |
Extranodal sites | Â | Â | 0.128 |
  < 2 | 11 (64.7%) | 97 (65.1%) |  |
  ≥ 2 | 6 (35.3%) | 52 (34.9%) |  |
Ann Arbor stage | Â | Â | 0.135 |
 I-II | 4 (23.5%) | 63 (42.3%) |  |
 III-IV | 13 (76.5%) | 86 (57.7%) |  |
HBcAb status |  |  | <  0.001 |
 Positive | 17 (100%) | 46 (30.9%) |  |
 Negative | 0 (0.0%) | 103 (69.1%) |  |
HBsAb status | Â | Â | 0.021 |
 Positive | 8 (47.1%) | 110 (73.8%) |  |
 Negative | 9 (52.9%) | 39 (26.2%) |  |